NCT00686426

Brief Summary

The goal of the current study is to determine the role of dairy in similarly preventing weight and fat re-gain in obese adults who have successfully completed a weight loss diet program.240 obese subjects will undergo a meal-replacement-based weight loss plan designed to produce a 10 kg weight loss in 8-12 weeks. Upon achieving the weight loss goal, subjects will be randomly assigned to either a low-dairy or high-dairy eucaloric weight maintenance diet for two years. Macronutrient distribution will be maintained constant and set at approximately the U.S. average. Primary outcomes include changes in body weight, body fat and anatomical distribution of fat (via dual x-ray absorptiometry) and resting metabolic rate and substrate oxidation (via respiratory calorimetry); Secondary outcomes include blood pressure, circulating glucose, insulin, lipids and calcitrophic hormones. on prevention of weight regain in humans has not yet been assessed in clinical trials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
338

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Nov 2003

Typical duration for not_applicable obesity

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2003

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2007

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 29, 2008

Completed
Last Updated

May 29, 2008

Status Verified

May 1, 2008

Enrollment Period

3.3 years

First QC Date

May 27, 2008

Last Update Submit

May 28, 2008

Conditions

Keywords

ObesityWeight gainregaindairycalcium

Outcome Measures

Primary Outcomes (2)

  • Body weight change

    6 months

  • Body Fat Change

    6 months

Study Arms (2)

1

ACTIVE COMPARATOR

Low Dairy

Dietary Supplement: Dairy Foods

2

EXPERIMENTAL

Adequate Dairy

Dietary Supplement: Dairy Foods

Interventions

Dairy FoodsDIETARY_SUPPLEMENT

Adequate dairy (\> 3 standard daily servings)

2

Eligibility Criteria

Age25 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index (BMI) 30-39.9 kg/m2
  • Age 25-50 years
  • No more than 3 kg weight loss during past three months
  • Negative pregnancy test at entry; women of childbearing potential may be enrolled if they have had a tubal ligation or use one of the following means of contraception: condom, diaphragm, oral or implanted contraceptives, or intrauterine device. Women in exclusive relationships with male partners who have had a successful vasectomy will not be required to use any additional means of birth control.

You may not qualify if:

  • BMI \< 30 or \>40
  • Type II diabetes requiring the use of any oral antidiabetic agent and/or insulin (because of confounding effects on body weight regulation)
  • Adverse response to study foods (lactose intolerance, dairy intolerance, dairy allergy); this will be determined by self-report.
  • History or presence of significant metabolic disease which could impact on the results of the study (i.e. endocrine, hepatic, renal disease)
  • History of eating disorder
  • Presence of active gastrointestinal disorders such as malabsorption syndromes
  • Pregnancy or lactation
  • Use of obesity pharmacotherapeutic agents within the last 6 months
  • Use of over-the-counter anti-obesity agents (e.g. those containing phenylpropanalamine, ephedrine and/or caffeine) within the last 6 months
  • Recent (past 12 weeks) use of tobacco
  • Recent (current or past 12 weeks) use of any psychotropic medication
  • Recent (past four weeks) initiation of an exercise program
  • Recent (past twelve weeks) initiation of hormone replacement therapy or change in HRT regimen
  • Recent (past twelve weeks) initiation of hormonal birth control or change in hormonal birth control regimen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Kansas

Lawrence, Kansas, 66045, United States

Location

The University of Tennessee

Knoxville, Tennessee, 37996-1920, United States

Location

Related Publications (2)

  • Zemel MB, Sun X, Sobhani T, Wilson B. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr. 2010 Jan;91(1):16-22. doi: 10.3945/ajcn.2009.28468. Epub 2009 Nov 4.

  • Zemel MB, Donnelly JE, Smith BK, Sullivan DK, Richards J, Morgan-Hanusa D, Mayo MS, Sun X, Cook-Wiens G, Bailey BW, Van Walleghen EL, Washburn RA. Effects of dairy intake on weight maintenance. Nutr Metab (Lond). 2008 Oct 24;5:28. doi: 10.1186/1743-7075-5-28.

MeSH Terms

Conditions

ObesityWeight Gain

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Michael B Zemel, PhD

    University of Tennessee

    PRINCIPAL INVESTIGATOR
  • Joseph E Donnelly, PhD

    University of Kansas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 27, 2008

First Posted

May 29, 2008

Study Start

November 1, 2003

Primary Completion

February 1, 2007

Study Completion

July 1, 2007

Last Updated

May 29, 2008

Record last verified: 2008-05

Locations